Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
OcugenOCGN |
-$8,000 | |
AmgenAMGN |
-$8,500 | |
Editas MedicineEDIT |
-$8,000 | |
United TherapeuticsUTHR |
-$210,000 | |
RegeneronREGN |
$16,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Christopher Jacobs Republican | Dec 12, 2022 | Sell | $1K - $15K |
Christopher Jacobs Republican | Oct 12, 2022 | Buy | $1K - $15K |
Who is the latest politician to buy or sell Anavex Life Sciences shares?
Christopher Jacobs sold Anavex Life Sciences shares most recently on December 12, 2022.
Which politician has bought the most AVXL stock in the last two years?
Christopher Jacobs has bought the most AVXL stock in the last 2 years, with an estimated value of $8,000.
Which politician has sold the most AVXL stock over the last two years?
Christopher Jacobs has sold the most AVXL stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading AVXL stock in the last 2 years?
There have been no US politicians buying or selling Anavex Life Sciences in the last 2 years.
How do insider transactions over the last 2 years reflect on Anavex Life Sciences' market confidence?
Over the last 2 years, insider transactions for Anavex Life Sciences have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.